In March, researchers in the Department of Biomedical Engineering—a shared department in the schools of Dental Medicine, Medicine, and Engineering—began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2). Today, the method is one step closer to being a cutting-edge diagnostics technology for rapid detection of infectious diseases.